Tirzepatide by Eli Lilly is a powerful new antidiabetic drug.
Regulatory
Actions of government agencies regulating the pharmaceutical industry: approval, rejection, and prohibition of drugs, granting special statuses.
Posted inInfections, Regulatory
Voquezna: New Drug for Acid-Related Gastrointestinal Diseases
Vonoprazan for Helicobacter pylori eradication and for treating erosive esophagitis, non-erosive gastroesophageal reflux disease (NERD), and gastroesophageal reflux disease (GERD).
Posted inInfections, New Drugs, Regulatory
Vivjoa: First Drug for Chronic Vaginal Yeast Infection
Oteseconazole by Mycovia Pharmaceuticals will prevent the risk of recurrent episodes of vulvovaginal candidiasis.
Posted inMetabolism, New Drugs, Regulatory
Camzyos: First Specific Drug to Treat Hypertrophic Cardiomyopathy
Mavacamten by Bristol-Myers Squibb is a new breath for all patients with obstructive hypertrophic cardiomyopathy.
Posted inAutoimmune Diseases, New Drugs, Rare/Orphan Diseases, Regulatory
Tepezza: First Drug for Thyroid Eye Disease
Teprotumumab by Horizon Therapeutics can really help with proptosis and diplopia in Graves’ disease and beyond.
Posted inNeuroscience, New Drugs, Regulatory
Oligomannate: Finally New Drug to Treat Alzheimer’s Disease
Innovative Chinese medicine eliminates gut microbiota dysbiosis, and it helps slow the progression of dementia in Alzheimer’s disease.
Posted inNew Drugs, Rare/Orphan Diseases, Regulatory
Vijoice: First Targeted Treatment for PIK3CA-Related Overgrowth Spectrum (PROS)
Novartis and its alpelisib will help with very rare diseases with malformations and excessive tissue growth.
